221 related articles for article (PubMed ID: 11394509)
21. Compound A production from sevoflurane is not less when KOH-free absorbent is used in a closed-circuit lung model system.
Versichelen L; Bouche MP; Struys M; Van Bocxlaer J; Mortier E; de Leenheer AP; Rolly G
Br J Anaesth; 2001 Mar; 86(3):345-8. PubMed ID: 11573522
[TBL] [Abstract][Full Text] [Related]
22. Production of compound A and carbon monoxide in circle systems: an in vitro comparison of two carbon dioxide absorbents.
Struys MM; Bouche MP; Rolly G; Vandevivere YD; Dyzers D; Goeteyn W; Versichelen LF; Van Bocxlaer JF; Mortier EP
Anaesthesia; 2004 Jun; 59(6):584-9. PubMed ID: 15144299
[TBL] [Abstract][Full Text] [Related]
23. Cardiorespiratory effects of low-flow and closed circuit inhalation anesthesia, using sevoflurane delivered with an in-circuit vaporizer and concentrations of compound A.
Muir WW; Gadawski J
Am J Vet Res; 1998 May; 59(5):603-8. PubMed ID: 9582964
[TBL] [Abstract][Full Text] [Related]
24. No compound a formation with Superia during minimal-flow sevoflurane anesthesia: a comparison with Sofnolime.
Bouche MP; Versichelen LF; Struys MM; Van Bocxlaer JF; De Leenheer AP; Mortier EP; Rolly G
Anesth Analg; 2002 Dec; 95(6):1680-5, table of contents. PubMed ID: 12456439
[TBL] [Abstract][Full Text] [Related]
25. Quantification of the degradation products of sevoflurane in two CO2 absorbants during low-flow anesthesia in surgical patients.
Frink EJ; Malan TP; Morgan SE; Brown EA; Malcomson M; Brown BR
Anesthesiology; 1992 Dec; 77(6):1064-9. PubMed ID: 1466458
[TBL] [Abstract][Full Text] [Related]
26. Baralyme dehydration increases and soda lime dehydration decreases the concentration of compound A resulting from sevoflurane degradation in a standard anesthetic circuit.
Eger EI; Ionescu P; Laster MJ; Weiskopf RB
Anesth Analg; 1997 Oct; 85(4):892-8. PubMed ID: 9322476
[TBL] [Abstract][Full Text] [Related]
27. Factors affecting the concentration of compound A resulting from the degradation of sevoflurane by soda lime and Baralyme in a standard anesthetic circuit.
Fang ZX; Eger EI
Anesth Analg; 1995 Sep; 81(3):564-8. PubMed ID: 7653824
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of low-flow sevoflurane anaesthesia for paediatric patients.
Igarashi M; Watanabe H; Iwasaki H; Namiki A
Acta Anaesthesiol Scand; 1999 Jan; 43(1):19-23. PubMed ID: 9926182
[TBL] [Abstract][Full Text] [Related]
29. Effects of fresh gas flow, tidal volume, and charcoal filters on the washout of sevoflurane from the Datex Ohmeda (GE) Aisys, Aestiva/5, and Excel 210 SE Anesthesia Workstations.
Sabouri AS; Lerman J; Heard C
Can J Anaesth; 2014 Oct; 61(10):935-42. PubMed ID: 25069780
[TBL] [Abstract][Full Text] [Related]
30. Compound A concentrations during low-flow sevoflurane anesthesia correlate directly with the concentration of monovalent bases in carbon dioxide absorbents.
Higuchi H; Adachi Y; Arimura S; Kanno M; Satoh T
Anesth Analg; 2000 Aug; 91(2):434-9. PubMed ID: 10910864
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting production of compound A from the interaction of sevoflurane with Baralyme and soda lime.
Fang ZX; Kandel L; Laster MJ; Ionescu P; Eger EI
Anesth Analg; 1996 Apr; 82(4):775-81. PubMed ID: 8615497
[TBL] [Abstract][Full Text] [Related]
32. Preparation of the Dräger Primus anesthetic machine for malignant hyperthermia-susceptible patients.
Prinzhausen H; Crawford MW; O'Rourke J; Petroz GC
Can J Anaesth; 2006 Sep; 53(9):885-90. PubMed ID: 16960266
[TBL] [Abstract][Full Text] [Related]
33. Sevoflurane degradation product concentrations with soda lime during prolonged anesthesia.
Frink EJ; Isner RJ; Malan TP; Morgan SE; Brown EA; Brown BR
J Clin Anesth; 1994; 6(3):239-42. PubMed ID: 8060632
[TBL] [Abstract][Full Text] [Related]
34. Sevoflurane degradation by carbon dioxide absorbents may produce more than one nephrotoxic compound in rats.
Stabernack CR; Eger EI; Warnken UH; Förster H; Hanks DK; Ferrell LD
Can J Anaesth; 2003 Mar; 50(3):249-52. PubMed ID: 12620947
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Amsorb, sodalime, and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound a in swine in vivo.
Kharasch ED; Powers KM; Artru AA
Anesthesiology; 2002 Jan; 96(1):173-82. PubMed ID: 11753018
[TBL] [Abstract][Full Text] [Related]
36. In vitro compound A formation in a computer-controlled closed-circuit anesthetic apparatus. Comparison with a classical valve circuit.
Versichelen LF; Rolly G; Bouche MP; Van Bocxlaer JF; Struys MM; Van Der Herten C; De Leenheer AP; Mortier EP
Anesthesiology; 2000 Oct; 93(4):1064-8. PubMed ID: 11020762
[TBL] [Abstract][Full Text] [Related]
37. Economic and Environmental Considerations During Low Fresh Gas Flow Volatile Agent Administration After Change to a Nonreactive Carbon Dioxide Absorbent.
Epstein RH; Dexter F; Maguire DP; Agarwalla NK; Gratch DM
Anesth Analg; 2016 Apr; 122(4):996-1006. PubMed ID: 26735317
[TBL] [Abstract][Full Text] [Related]
38. Amsorb: a new carbon dioxide absorbent for use in anesthetic breathing systems.
Murray JM; Renfrew CW; Bedi A; McCrystal CB; Jones DS; Fee JP
Anesthesiology; 1999 Nov; 91(5):1342-8. PubMed ID: 10551585
[TBL] [Abstract][Full Text] [Related]
39. Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents. Quantification of degradation products in the circuit.
Bito H; Ikeda K
Anesthesiology; 1994 Aug; 81(2):340-5. PubMed ID: 8053583
[TBL] [Abstract][Full Text] [Related]
40. Compound A concentration in the circle absorber system during low-flow sevoflurane anesthesia: comparison of Drägersorb Free, Amsorb, and Sodasorb II.
Kobayashi S; Bito H; Obata Y; Katoh T; Sato S
J Clin Anesth; 2003 Feb; 15(1):33-7. PubMed ID: 12657409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
